Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins and screening methods for modulators

Details for Australian Patent Application No. 2006235995 (hide)

Owner Ludwig Institute for Cancer Research Licentia Ltd

Inventors Jeltsch, Markku Michael; Alitalo, Kari

Agent Griffith Hack

Pub. Number AU-A-2006235995

Parent 2001239884

Filing date 10 November 2006

Wipo publication date 7 December 2006

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

30 November 2006 Complete Application Filed

7 December 2006 Application Open to Public Inspection

  Published as AU-A-2006235995

24 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235996-Wheelie bins - street advertisment

2006235994-An apparatus for producing a feed mixture for animals